宏川智慧(002930.SZ):子公司完成收購長江石化30.4%股權
格隆匯 2 月 28日丨宏川智慧(002930.SZ)公佈,之前公吿披露,公司於2020年3月23日召開了第二屆董事會第二十二次會議,審議通過了《關於子公司競拍收購股權的議案》,同意公司全資子公司南通陽鴻石化儲運有限公司(“南通陽鴻”)在董事會權限範圍內,通過公開摘牌受讓方式競拍收購中遠海運港口發展有限公司持有的江蘇長江石油化工有限公司(“長江石化”)30.4%股權。
長江石化現已辦理完成上述股權收購相關工商變更登記手續,並取得了太倉市市場監督管理局換髮的《營業執照》。
此次工商變更登記手續辦理完畢後,公司通過南通陽鴻間接持有長江石化30.40%股權,長江石化為公司子公司參股公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.